Trials are reviewing combinations like GLP-1/GIP/GCG receptor agonists, which are looking promising in early studies
When youre ready, gently pinch the injection site to make the area tighter
Semaglutide is approved for use in obese individuals with a body mass index (BMI) of 30 kg/m2 or higher or overweight individuals with a BMI of 27 kg/m2 or higher and at least one weight-related condition such as high blood pressure, high blood sugar, or high cholesterol
Introduction Maintaining cardiovascular health is a primary concern for many health-conscious adults today
Whilst there is no absolute contraindication to using Wegovy in patients with hiatus hernia, the medication slows gastric emptying, which may worsen reflux symptoms
The patient has a body mass index (BMI) of 30 kg/m, or